278 related articles for article (PubMed ID: 15331446)
1. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells.
Münz C; Dao T; Ferlazzo G; de Cos MA; Goodman K; Young JW
Blood; 2005 Jan; 105(1):266-73. PubMed ID: 15331446
[TBL] [Abstract][Full Text] [Related]
2. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
Ratzinger G; Baggers J; de Cos MA; Yuan J; Dao T; Reagan JL; Münz C; Heller G; Young JW
J Immunol; 2004 Aug; 173(4):2780-91. PubMed ID: 15294997
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.
Ferlazzo G; Pack M; Thomas D; Paludan C; Schmid D; Strowig T; Bougras G; Muller WA; Moretta L; Münz C
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16606-11. PubMed ID: 15536127
[TBL] [Abstract][Full Text] [Related]
4. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.
Ferlazzo G; Tsang ML; Moretta L; Melioli G; Steinman RM; Münz C
J Exp Med; 2002 Feb; 195(3):343-51. PubMed ID: 11828009
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
Anguille S; Lion E; Tel J; de Vries IJ; Couderé K; Fromm PD; Van Tendeloo VF; Smits EL; Berneman ZN
PLoS One; 2012; 7(12):e51851. PubMed ID: 23284789
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal activating interaction between natural killer cells and dendritic cells.
Gerosa F; Baldani-Guerra B; Nisii C; Marchesini V; Carra G; Trinchieri G
J Exp Med; 2002 Feb; 195(3):327-33. PubMed ID: 11828007
[TBL] [Abstract][Full Text] [Related]
8. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
Milush JM; Long BR; Snyder-Cappione JE; Cappione AJ; York VA; Ndhlovu LC; Lanier LL; Michaëlsson J; Nixon DF
Blood; 2009 Nov; 114(23):4823-31. PubMed ID: 19805616
[TBL] [Abstract][Full Text] [Related]
9. CD34-derived human Langerhans cells stimulate a T helper type 2 response independently of extracellular-signal-regulated kinase phosphorylation.
Duraisingham SS; Hornig J; Gotch F; Patterson S
Immunology; 2010 Oct; 131(2):210-9. PubMed ID: 20465567
[TBL] [Abstract][Full Text] [Related]
10. TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses.
Duraisingham SS; Hornig J; Gotch F; Patterson S
J Immunol; 2009 Aug; 183(4):2242-51. PubMed ID: 19625644
[TBL] [Abstract][Full Text] [Related]
11. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.
Gerosa F; Gobbi A; Zorzi P; Burg S; Briere F; Carra G; Trinchieri G
J Immunol; 2005 Jan; 174(2):727-34. PubMed ID: 15634892
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells trigger differentiation of monocytes into dendritic cells.
Zhang AL; Colmenero P; Purath U; Teixeira de Matos C; Hueber W; Klareskog L; Tarner IH; Engleman EG; Söderström K
Blood; 2007 Oct; 110(7):2484-93. PubMed ID: 17626840
[TBL] [Abstract][Full Text] [Related]
14. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood.
Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ
Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068
[TBL] [Abstract][Full Text] [Related]
15. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
16. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood dendritic cells, but not monocyte-derived dendritic cells, can augment human NK cell function.
Osada T; Nagawa H; Kitayama J; Tsuno NH; Ishihara S; Takamizawa M; Shibata Y
Cell Immunol; 2001 Oct; 213(1):14-23. PubMed ID: 11747352
[TBL] [Abstract][Full Text] [Related]
18. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
19. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction.
Newland A; Russ G; Krishnan R
Immunology; 2006 Jun; 118(2):216-23. PubMed ID: 16771856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]